Literature DB >> 19248775

Visible and near-infrared spectral changes in the thumb of patients with chronic fatigue syndrome.

Akikazu Sakudo1, Yukiko Hakariya Kato, Seiki Tajima, Hirohiko Kuratsune, Kazuyoshi Ikuta.   

Abstract

BACKGROUND: Chronic fatigue syndrome (CFS) patients show a persistent fatigue condition with muscle pain and impairment of concentration, memory, and sleep. Presently, the physiological basis of CFS remains unclear. In this study, spectroscopic differences in the thumb were compared between 103 CFS patients and 122 healthy controls to examine possible changes of levels of oxygenated or deoxygenated hemoglobin.
METHODS: Visible and near-infrared (Vis-NIR) spectroscopy was used to examine possible changes in the region of 600-1100 nm.
RESULTS: Vis-NIR spectra showed sharp peaks at 694, 970 and 1060 nm and broad peaks in the regions of 740-760 and 830-850 nm. As these peaks are possibly related to oxyhemoglobin, cytochrome c oxidase and water, levels of these factors were compared between the two groups. Statistical analysis of the absorbance of Vis-NIR spectra showed a significant decrease in water content, a significant increase in oxyhemoglobin content, and a significant increase in the oxidation of heme a+a(3) and copper in cytochrome c oxidase in CFS patients.
CONCLUSIONS: These changes imply accelerated blood flow and energy metabolism in the thumbs of CFS patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19248775     DOI: 10.1016/j.cca.2009.02.010

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  Multispectral imaging in the extended near-infrared window based on endogenous chromophores.

Authors:  Qian Cao; Natalia G Zhegalova; Steven T Wang; Walter J Akers; Mikhail Y Berezin
Journal:  J Biomed Opt       Date:  2013-10       Impact factor: 3.170

2.  Non-invasive prediction of hemoglobin levels by principal component and back propagation artificial neural network.

Authors:  Haiquan Ding; Qipeng Lu; Hongzhi Gao; Zhongqi Peng
Journal:  Biomed Opt Express       Date:  2014-03-12       Impact factor: 3.732

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.